Forging ahead through innovation: Pfizer’s strategic progress in Q2 2025
Overview In the second quarter of 2025, Pfizer advanced its mission to deliver breakthroughs that change patients’ lives, supported by a diversified product portfolio, innovation in R&D, and disciplined operational execution. The company navigated a dynamic healthcare landscape by strengthening its leadership in core therapeutic areas, expanding access to critical medicines, and progressing its pipeline…
